Next Article in Journal
Resolving Intra- and Inter-Molecular Structure with Non-Contact Atomic Force Microscopy
Next Article in Special Issue
Role of RUNX2 in Breast Carcinogenesis
Previous Article in Journal
Regulatory Roles of Non-Coding RNAs in Colorectal Cancer
Previous Article in Special Issue
Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2015, 16(8), 19920-19935; doi:10.3390/ijms160819920

Selection and Characterization of Single Chain Antibody Fragments Specific for Hsp90 as a Potential Cancer Targeting Molecule

1
Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383 Wroclaw, Poland
2
Wroclaw Research Centre EIT+, Stablowicka 147, 54-066 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
Academic Editor: William Chi-shing Cho
Received: 24 April 2015 / Revised: 2 June 2015 / Accepted: 15 July 2015 / Published: 21 August 2015
(This article belongs to the Collection Advances in Molecular Oncology)
View Full-Text   |   Download PDF [21991 KB, uploaded 21 August 2015]   |  

Abstract

Heat shock proteins play an essential role in facilitating malignant transformation and they have been recognized as important factors in human cancers. One of the key elements of the molecular chaperones machinery is Hsp90 and it has recently become a target for anticancer therapeutic approaches. The potential and importance of Hsp90-directed agents becomes apparent when one realizes that disruption of Hsp90 function may influence over 200 oncogenic client proteins. Here, we described the selection and characterization of Hsp90-specific antibody fragments from commercially available Tomlinson I and J phage display libraries. The affinities of Hsp90-binding scFv variants were measured using SPR method. Then, based on the best clone selected, we performed the affinity maturation procedure and obtained valuable Hsp90-specific clones. The selected binders were expressed and applied for immunostaining, ELISA and SPR analysis using model cancer cell lines. All performed experiments confirmed the ability of selected antibodies to interact with the Hsp90. Therefore, the presented Hsp90-specific scFv, might be a starting point for the development of a novel antibody-based strategy targeting cancer. View Full-Text
Keywords: antibody fragments; cancer marker; Heat Shock Protein 90; phage display antibody fragments; cancer marker; Heat Shock Protein 90; phage display
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Petters, E.; Sokolowska-Wedzina, A.; Otlewski, J. Selection and Characterization of Single Chain Antibody Fragments Specific for Hsp90 as a Potential Cancer Targeting Molecule. Int. J. Mol. Sci. 2015, 16, 19920-19935.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top